NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.

Transcription

1 Diagnosing venous thromboembolism in primary, secondary and tertiary care NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic. NICE Pathways are interactive and designed to be used online. They are updated regularly as new NICE guidance is published. To view the latest version of this pathway see: Pathway last updated: 26 April 2016 This document contains a single pathway diagram and uses numbering to link the boxes to the associated recommendations. All rights reserved

2 Page 2 of 15

3 1 Adult with signs or symptoms of deep vein thrombosis or pulmonary embolism No additional information 2 Initial diagnostic investigations Deep vein thrombosis If a patient presents with signs or symptoms of DVT, carry out an assessment of their general medical history and a physical examination to exclude other causes. Pulmonary embolism If a patient presents with signs or symptoms of PE, carry out an assessment of their general medical history, a physical examination and a chest X-ray to exclude other causes. Patient with signs and symptoms of both deep vein thrombosis and pulmonary embolism If a patient presents with signs or symptoms of both DVT (for example a swollen and/or painful leg) and PE (for example chest pain, shortness of breath or haemoptysis), carry out initial diagnostic investigations for either DVT or PE, basing the choice of diagnostic investigations on clinical judgement. Quality standards The following quality statements are relevant to this part of the pathway. Venous thromboembolism in adults: diagnosis and management quality standard 1. Interim therapeutic dose of anticoagulation therapy for suspected deep vein thrombosis 2. Diagnosis of deep vein thrombosis 3. Interim therapeutic dose of anticoagulation therapy for suspected pulmonary embolism Page 3 of 15

4 3 Estimate clinical probability using two-level Wells score Deep vein thrombosis If DVT is suspected, use the two-level DVT Wells score [See page 9] to estimate the clinical probability of DVT. Pulmonary embolism If PE is suspected, use the two-level PE Wells score [See page 10] to estimate the clinical probability of PE. Quality standards The following quality statements are relevant to this part of the pathway. Venous thromboembolism in adults: diagnosis and management quality standard 1. Interim therapeutic dose of anticoagulation therapy for suspected deep vein thrombosis 2. Diagnosis of deep vein thrombosis 3. Interim therapeutic dose of anticoagulation therapy for suspected pulmonary embolism 4 Deep vein thrombosis likely Offer patients in whom DVT is suspected and with a likely two-level DVT Wells score [See page 9] either: a proximal leg vein ultrasound scan carried out within 4 hours of being requested and, if the result is negative, a D-dimer test or a D-dimer test and an interim 24-hour dose of a parenteral anticoagulant (if a proximal leg vein ultrasound scan cannot be carried out within 4 hours) and a proximal leg vein ultrasound scan carried out within 24 hours of being requested. Repeat the proximal leg vein ultrasound scan 6 8 days later for all patients with a positive D- dimer test and a negative proximal leg vein ultrasound scan. Page 4 of 15

5 Diagnose DVT and treat patients with a positive proximal leg vein ultrasound scan (see treating venous thromboembolism in this pathway). When to consider alternative diagnoses Take into consideration alternative diagnoses in patients with: a likely two-level DVT Wells score [See page 9] and a negative proximal leg vein ultrasound scan and a negative D-dimer test or a repeat negative proximal leg vein ultrasound scan. Advise patients that it is not likely they have DVT, and discuss with them the signs and symptoms of DVT and when and where to seek further medical help. Quality standards The following quality statements are relevant to this part of the pathway. Venous thromboembolism in adults: diagnosis and management quality standard 1. Interim therapeutic dose of anticoagulation therapy for suspected deep vein thrombosis 2. Diagnosis of deep vein thrombosis 5 Deep vein thrombosis unlikely Offer patients in whom DVT is suspected and with an unlikely two-level DVT Wells score [See page 9] a D-dimer test and if the result is positive offer either: a proximal leg vein ultrasound scan carried out within 4 hours of being requested or an interim 24-hour dose of a parenteral anticoagulant (if a proximal leg vein ultrasound scan cannot be carried out within 4 hours and a proximal leg vein ultrasound scan carried out within 24 hours of being requested. Diagnose DVT and treat patients with a positive proximal leg vein ultrasound scan (see treating venous thromboembolism in this pathway). When to consider alternative diagnoses Take into consideration alternative diagnoses in patients with: Page 5 of 15

6 an unlikely two-level DVT Wells score [See page 9] and a negative D-dimer test or a positive D-dimer test and a negative proximal leg vein ultrasound scan. Advise patients that it is not likely they have DVT, and discuss with them the signs and symptoms of DVT and when and where to seek further medical help. Quality standards The following quality statements are relevant to this part of the pathway. Venous thromboembolism in adults: diagnosis and management quality standard 1. Interim therapeutic dose of anticoagulation therapy for suspected deep vein thrombosis 2. Diagnosis of deep vein thrombosis 6 Pulmonary embolism likely Offer patients in whom PE is suspected and with a likely two-level PE Wells score [See page 10] either: an immediate CTPA or immediate interim parenteral anticoagulant therapy followed by a CTPA, if a CTPA cannot be carried out immediately. Consider a proximal leg vein ultrasound scan if the CTPA is negative and DVT is suspected. For patients who have an allergy to contrast media, or who have renal impairment, or whose risk from irradiation is high: Assess the suitability of a V/Q SPECT scan or, if a V/Q SPECT scan is not available, a V/Q planar scan, as an alternative to CTPA. If offering a V/Q SPECT or planar scan that will not be available immediately, offer immediate interim parenteral anticoagulant therapy. Diagnose PE and treat patients with a positive CTPA or in whom PE is identified with a V/Q SPECT or planar scan (see the recommendations on treatment in this pathway). Page 6 of 15

7 When to consider alternative diagnoses Take into consideration alternative diagnoses in patients with a likely two-level PE Wells score [See page 10] and both: a negative CTPA and no suspected DVT. Advise these patients that it is not likely they have PE and discuss with them the signs and symptoms of PE, and when and where to seek further medical help. Quality standards The following quality statement is relevant to this part of the pathway. Venous thromboembolism in adults: diagnosis and management quality standard 3. Interim therapeutic dose of anticoagulation therapy for suspected pulmonary embolism 7 Pulmonary embolism unlikely Offer patients in whom PE is suspected and with an unlikely two-level PE Wells score [See page 10] a D-dimer test and if the result is positive offer either: an immediate CTPA or immediate interim parenteral anticoagulant therapy followed by a CTPA, if a CTPA cannot be carried out immediately. For patients who have an allergy to contrast media, or who have renal impairment, or whose risk from irradiation is high: Assess the suitability of a V/Q SPECT scan or, if a V/Q SPECT scan is not available, a V/Q planar scan, as an alternative to CTPA. If offering a V/Q SPECT or planar scan that will not be available immediately, offer immediate interim parenteral anticoagulant therapy. Diagnose PE and treat patients with a positive CTPA or in whom PE is identified with a V/Q SPECT or planar scan (see the recommendations on treatment in this pathway). Page 7 of 15

8 When to consider alternative diagnoses Take into consideration alternative diagnoses in patients with an unlikely two-level PE Wells score [See page 10] and either: a negative D-dimer test or a positive D-dimer test and a negative CTPA. Advise these patients that it is not likely they have PE and discuss with them the signs and symptoms of PE, and when and where to seek further medical help. Quality standards The following quality statement is relevant to this part of the pathway. Venous thromboembolism in adults: diagnosis and management quality standard 3. Interim therapeutic dose of anticoagulation therapy for suspected pulmonary embolism 8 Treatment See Venous thromboembolism / Treating venous thromboembolism Page 8 of 15

9 Two-level DVT Wells score 1 Clinical feature Points Active cancer (treatment ongoing, within 6 months, or palliative) 1 Paralysis, paresis or recent plaster immobilisation of the lower extremities 1 Recently bedridden for 3 days or more, or major surgery within 12 weeks requiring general or regional anaesthesia 1 Localised tenderness along the distribution of the deep venous system 1 Entire leg swollen 1 Calf swelling 3 cm larger than asymptomatic side 1 Pitting oedema confined to the symptomatic leg 1 Collateral superficial veins (non-varicose) 1 Previously documented DVT 1 An alternative diagnosis is at least as likely as DVT 2 Clinical probability simplified score Points DVT likely 2 points or more 1 Adapted with permission from Wells PS et al. (2003) Evaluation of D-dimer in the diagnosis of suspected deepvein thrombosis. Page 9 of 15

10 DVT unlikely 1 point or less Two-level PE Wells score 1 Clinical feature Points Clinical signs and symptoms of DVT (minimum of leg swelling and pain with palpation of the deep veins) 3 An alternative diagnosis is less likely than PE 3 Heart rate > 100 beats per minute 1.5 Immobilisation for more than 3 days or surgery in the previous 4 weeks 1.5 Previous DVT/PE 1.5 Haemoptysis 1 Malignancy (on treatment, treated in the last 6 months, or palliative) 1 Clinical probability simplified score Points PE likely More than 4 points PE unlikely 4 points or less Page 10 of 15

11 1 Adapted with permission from Wells PS et al. (2000) Derivation of a simple clinical model to categorize patients' probability of pulmonary embolism: increasing the model's utility with the SimpliRED D-dimer. Page 11 of 15

12 Glossary APTT activated partial thromboplastin time CTPA computed tomography pulmonary angiogram D-dimer test D-dimer is a product formed in the body when a blood clot (such as those found in DVT or PE) is broken down. A laboratory or point of care test can be done to assess the concentration of D- dimer in a person's blood. The threshold for a positive result varies with the type of D-dimer test used and is determined locally. The result of the D-dimer test can be used as part of probability assessment when DVT or PE is suspected. DVT deep vein thrombosis Fondaparinux fondaparinux sodium HRT hormone replacement therapy INR international normalised ratio (a standardised laboratory measure of blood coagulation used to monitor the adequacy of anticoagulation in patients who are having treatment with a vitamin K antagonist) LMWH Low molecular weight heparin Page 12 of 15

13 Major bleeding a bleeding event that results in one or more of the following: death, a decrease in haemoglobin concentration of 2 g/dl, transfusion of 2 units of blood, bleeding into a retroperitoneal, intracranial or intraocular site, a serious or life-threatening clinical event, a surgical or medical intervention PE pulmonary embolism Proximal in the popliteal vein or above; sometimes referred to as 'above-knee' Provoked occurring in a patient with an antecedent (within 3 months) and transient major clinical risk factor for venous thromboembolism for example surgery, trauma, significant immobility (bedbound, unable to walk unaided or likely to spend a substantial proportion of the day in bed or in a chair), pregnancy or puerperium or in a patient who is having hormonal therapy (oral contraceptive or hormone replacement therapy) Renal impairment Reduced renal function that may be acute or chronic. An estimated glomerular filtration rate (egfr) < 90 ml/min/1.73 m 2 indicates a degree of renal impairment in chronic kidney disease. For NICE guidance on the classification of chronic kidney disease see stages of CKD and frequency of egfr testing in the NICE pathway on chronic kidney disease. Severe renal impairment or established renal failure estimated glomerular filtration rate of less than 30 ml/min/1.73m 2 Significantly reduced mobility bedbound, unable to walk unaided or likely to spend a substantial proportion of the day in bed or in a chair Page 13 of 15

14 UFH unfractionated heparin Unprovoked occurring in a patient with: no antecedent major clinical risk factor for venous thromboembolism for example surgery, trauma, significant immobility (bedbound, unable to walk unaided or likely to spend a substantial proportion of the day in bed or in a chair), pregnancy or puerperium who is not having hormonal therapy (oral contraceptive or hormone replacement therapy) or active cancer, thrombophilia or a family history of venous thromboembolism, because these are underlying risks that remain constant in the patient V/Q SPECT ventilation/perfusion single photon emission computed tomography VTE venous thromboembolism Wells score a clinical prediction rule for estimating the probability of deep vein thrombosis (DVT) or pulmonary embolism (PE). There are a number of versions of Wells scores available. This pathway recommends the two-level DVT Wells score and the two-level PE Wells score Sources Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (2012 updated 2015) NICE guideline CG144 Your responsibility The guidance in this pathway represents the view of NICE, which was arrived at after careful consideration of the evidence available. Those working in the NHS, local authorities, the wider public, voluntary and community sectors and the private sector should take it into account when carrying out their professional, managerial or voluntary duties. Implementation of this guidance is the responsibility of local commissioners and/or providers. Commissioners and providers are Page 14 of 15

15 reminded that it is their responsibility to implement the guidance, in their local context, in light of their duties to avoid unlawful discrimination and to have regard to promoting equality of opportunity. Nothing in this guidance should be interpreted in a way which would be inconsistent with compliance with those duties. Copyright Copyright National Institute for Health and Care Excellence All rights reserved. NICE copyright material can be downloaded for private research and study, and may be reproduced for educational and not-for-profit purposes. No reproduction by or for commercial organisations, or for commercial purposes, is allowed without the written permission of NICE. Contact NICE National Institute for Health and Care Excellence Level 1A, City Tower Piccadilly Plaza Manchester M1 4BT nice@nice.org.uk Page 15 of 15